Literature DB >> 10849442

Do structural deviations between toxins adopting the same fold reflect functional differences?

A Ricciardi1, M H le Du, M Khayati, F Dajas, J C Boulain, A Menez, F Ducancel.   

Abstract

Three-finger proteins form a structurally related family of compounds that exhibit a great variety of biological properties. To address the question of the prediction of functional areas on their surfaces, we tentatively conferred the acetylcholinesterase inhibitory activity of fasciculins on a short-chain curaremimetic toxin. For this purpose, we assimilated the three-dimensional structure of fasciculin 2 with the one of toxin alpha. This comparison revealed that the tips of the first and second loops, together with the C terminus residue, deviated most. A first recombinant fasciculin/toxin alpha chimera was designed by transferring loop 1 in its entirety together with the tip of loop 2 of fasciculin 2 into the toxin alpha scaffold. A second chimera (rChII) was obtained by adding the point Asn-61 --> Tyr substitution. Comparison of functional and structural properties of both chimeras show that rChII can accommodate the imposed modifications and displays nearly all the acetylcholinesterase-blocking activities of fasciculins. The three-dimensional structure of rChII demonstrates that rChII adopts a typical three-fingered fold with structural features of both parent toxins. Taken together, these results emphasize the great structural flexibility and functional adaptability of that fold and confirm that structural deviations between fasciculins and short-chain neurotoxins do indeed reflect functional diversity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10849442     DOI: 10.1074/jbc.275.24.18302

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Cytotoxic potency of cardiotoxin from Naja sputatrix: development of a new cytolytic assay.

Authors:  Donghui Ma; Arunmozhiarasi Armugam; Kandiah Jeyaseelan
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

2.  Motions and structural variability within toxins: implication for their use as scaffolds for protein engineering.

Authors:  Bernard Gilquin; Marjorie Bourgoin; Renée Ménez; Marie-Hélène Le Du; Denis Servent; Sophie Zinn-Justin; André Ménez
Journal:  Protein Sci       Date:  2003-02       Impact factor: 6.725

3.  Fulditoxin, representing a new class of dimeric snake toxins, defines novel pharmacology at nicotinic ACh receptors.

Authors:  Chun Shin Foo; Chacko Jobichen; Varuna Hassan-Puttaswamy; Zoltan Dekan; Han-Shen Tae; Daniel Bertrand; David J Adams; Paul F Alewood; J Sivaraman; Selvanayagam Nirthanan; R Manjunatha Kini
Journal:  Br J Pharmacol       Date:  2020-02-09       Impact factor: 8.739

4.  Novel genes encoding six kinds of three-finger toxins in Ophiophagus hannah (king cobra) and function characterization of two recombinant long-chain neurotoxins.

Authors:  Jing Li; Huayuan Zhang; Jing Liu; Kangsen Xu
Journal:  Biochem J       Date:  2006-09-01       Impact factor: 3.857

5.  Structural and functional characterization of a novel homodimeric three-finger neurotoxin from the venom of Ophiophagus hannah (king cobra).

Authors:  Amrita Roy; Xingding Zhou; Ming Zhi Chong; Dieter D'hoedt; Chun Shin Foo; Nandhakishore Rajagopalan; Selvanayagam Nirthanan; Daniel Bertrand; J Sivaraman; R Manjunatha Kini
Journal:  J Biol Chem       Date:  2010-01-13       Impact factor: 5.157

6.  Identification and structural characterization of a new three-finger toxin hemachatoxin from Hemachatus haemachatus venom.

Authors:  Vallerinteavide Mavelli Girish; Sundramurthy Kumar; Lissa Joseph; Chacko Jobichen; R Manjunatha Kini; J Sivaraman
Journal:  PLoS One       Date:  2012-10-29       Impact factor: 3.240

7.  Engineering of three-finger fold toxins creates ligands with original pharmacological profiles for muscarinic and adrenergic receptors.

Authors:  Carole Fruchart-Gaillard; Gilles Mourier; Guillaume Blanchet; Laura Vera; Nicolas Gilles; Renée Ménez; Elodie Marcon; Enrico A Stura; Denis Servent
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.